Pharmigene, Inc. (TPEX:7595)
Taiwan · Delayed Price · Currency is TWD 9.74
-0.11 (-1.12%)
At close: May 8, 2026
Pharmigene Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -73 | -82.86 | -72.65 | -42.72 | -23.43 |
Depreciation & Amortization | 25.7 | 23.69 | 22.81 | 19.65 | 15.02 |
Other Amortization | - | 0.29 | 0.06 | 0.12 | 0.18 |
Loss (Gain) From Sale of Assets | - | -0 | - | -0.4 | - |
Asset Writedown & Restructuring Costs | 5 | -0.13 | 2.05 | - | - |
Loss (Gain) From Sale of Investments | 2.46 | -14.46 | 0.51 | -0.21 | - |
Loss (Gain) on Equity Investments | 0.35 | 4.51 | 4.6 | 0.72 | 1.44 |
Provision & Write-off of Bad Debts | -1.64 | 3.95 | 0.07 | 0.59 | -1.44 |
Other Operating Activities | -0.47 | -0.28 | 0.45 | -0.09 | 1.76 |
Change in Accounts Receivable | -36.03 | 7.37 | 0.94 | -9.18 | -2.6 |
Change in Inventory | 9.45 | -26.24 | 1.13 | -9.87 | -7.73 |
Change in Accounts Payable | 7.41 | 6.47 | 0.76 | 4.32 | -0.01 |
Change in Unearned Revenue | 6.7 | 1.71 | -7.05 | 6.33 | -1.16 |
Change in Other Net Operating Assets | -12.93 | 5.94 | -6.21 | 7.28 | -1.33 |
Operating Cash Flow | -66.99 | -44.82 | -77.54 | -23.47 | -19.31 |
Capital Expenditures | -8.34 | -64.6 | -665.31 | -10.5 | -12.67 |
Sale of Property, Plant & Equipment | - | 2.12 | - | 0.93 | - |
Sale (Purchase) of Intangibles | -1.06 | -2.38 | -2.5 | -0.08 | -6 |
Investment in Securities | 2.99 | 87.02 | 9.27 | 19.1 | -62.83 |
Other Investing Activities | 0.4 | -1.07 | 1.11 | -4.55 | -0.78 |
Investing Cash Flow | -6.02 | 21.1 | -657.43 | 4.9 | -82.28 |
Short-Term Debt Issued | 96.16 | 12 | 70 | - | - |
Long-Term Debt Issued | - | 51 | 559.4 | - | - |
Total Debt Issued | 96.16 | 63 | 629.4 | - | - |
Short-Term Debt Repaid | -29.08 | -12 | -70 | - | - |
Long-Term Debt Repaid | -29.67 | -4.03 | -7.2 | -7.01 | -6.89 |
Total Debt Repaid | -58.75 | -16.03 | -77.2 | -7.01 | -6.89 |
Net Debt Issued (Repaid) | 37.41 | 46.97 | 552.2 | -7.01 | -6.89 |
Issuance of Common Stock | - | - | 175 | - | - |
Other Financing Activities | -0.18 | 0.31 | -0.56 | -2.17 | - |
Financing Cash Flow | 37.24 | 47.28 | 726.65 | -9.18 | -6.89 |
Foreign Exchange Rate Adjustments | -0.09 | 0.25 | -0 | 0.32 | -0.01 |
Net Cash Flow | -35.86 | 23.81 | -8.33 | -27.43 | -108.49 |
Free Cash Flow | -75.33 | -109.42 | -742.85 | -33.96 | -31.98 |
Free Cash Flow Margin | -37.69% | -93.90% | -559.76% | -25.38% | -24.72% |
Free Cash Flow Per Share | -1.50 | -2.17 | -16.33 | -0.78 | -0.74 |
Cash Interest Paid | - | 11.97 | 7.08 | 0.2 | 0.31 |
Cash Income Tax Paid | - | 0.19 | 0.09 | 0.02 | 1.12 |
Levered Free Cash Flow | -49.57 | -96.7 | -719.91 | -19.55 | -24.35 |
Unlevered Free Cash Flow | -40.54 | -89.13 | -714.97 | -19.43 | -24.16 |
Change in Working Capital | -25.39 | 20.48 | -35.44 | -1.13 | -12.83 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.